The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a phase II of metformin plus irinotecan for refractory colorectal cancer.
 
Arinilda Bragagnoli
No Relationships to Disclose
 
Rapahel Araujo
No Relationships to Disclose
 
Kathia Abdalla
Honoraria - Roche
Research Funding - Novartis (Inst); Roche (Inst)
 
Fabiana Comar
No Relationships to Disclose
 
Florinda Santos
No Relationships to Disclose
 
Mauricio Ferraz
No Relationships to Disclose
 
Lucas Vieira dos Santos
Consulting or Advisory Role - Lilly
Research Funding - Amgen (Inst); Boston Scientific (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Jose Carvalheira
No Relationships to Disclose
 
Joao PsDN Lima
Honoraria - AstraZeneca; BMS Brazil; Johnson & Johnson; Novartis; Roche
Consulting or Advisory Role - Roche
Speakers' Bureau - Novartis; Roche